252049-06-2

Basic information

• Product Name: FMOC-N-ME-THR-OH
• Synonyms: FMOC-METHR-OH;FMOC-N-ME-THR-OH;FMOC-N-ME-THREONINE;FMOC-N-METHYL-L-THREONINE;FMOC-L-METHR-OH;N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-ALPHA-METHYL-L-THREONINE;N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-ALPHA-METHYL-L-THREONINE;Fmoc-N-Me-D-Thr-OH
• CAS NO: 252049-06-2
• Molecular Formula: C20H21NO5
• Molecular Weight: 355.38
• Product Categories: amino acids
• Mol File: 252049-06-2.mol

Chemical Properties

• Boiling Point: 566.4±50.0 °C(Predicted)
• Appearance: /
• Density: 1.306±0.06 g/cm3(Predicted)
• Storage Temp.: Store at RT.
• PKA: 3.50±0.10(Predicted)
• CAS DataBase Reference: FMOC-N-ME-THR-OH(CAS DataBase Reference)
• NIST Chemistry Reference: FMOC-N-ME-THR-OH(252049-06-2)
• EPA Substance Registry System: FMOC-N-ME-THR-OH(252049-06-2)

Safety Data

• Hazardous Substances Data: 252049-06-2(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry Research:
FMOC-N-ME-THR-OH is used as a building block for the synthesis of peptides and proteins due to its role as a derivative of threonine, an essential amino acid. Its FMOC group provides protection during the synthesis process, enabling selective modification and manipulation of the amino acid in the creation of complex molecules.
Used in Biochemistry Research:
In biochemistry, FMOC-N-ME-THR-OH is utilized for the development of peptide-based drugs and materials. Its protective FMOC group allows for precise control over the synthesis process, which is crucial for the production of biologically active compounds with specific functions and properties.
Used in Pharmaceutical Development:
FMOC-N-ME-THR-OH is used as a key component in the synthesis of peptide-based drugs. Its protective group facilitates the production of pharmaceuticals with targeted therapeutic effects, contributing to the advancement of medicine and healthcare.
Used in Material Science:
In material science, FMOC-N-ME-THR-OH contributes to the development of novel materials with specific properties. Its role in peptide synthesis allows for the creation of biomaterials with tailored characteristics for various applications, such as drug delivery systems or tissue engineering scaffolds.

Upstream product

• 2360825-89-2 Fmoc-N-Me-D-Thr(tBu)-OH 
• 117106-20-4 (2S,3R)-3-tert-butoxy-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}butanoic acid 
• 181817-14-1 N^α-(9-fluorenylmethoxycarbonyl)-O-acetyl-L-threonine 
• 946845-45-0 C₂₂H₂₁NO₆ 

Downstream Products

• 1353654-66-6 (2S,3R)-benzyl 2-methylamino-3-((triisopropylsilyl)oxy)butanoate 
• 1353654-76-8 (5S)-4-(benzyloxy)-1-methyl-5-{(1R)-1-[(triisopropylsilyl)oxy]ethyl}-1H-pyrrol-2(5H)-one 

Relevant articles and documents

An improved synthesis of Fmoc-N-methyl serine and threonine

An improved method for the synthesis of Fmoc-N-methyl serine and threonine has been developed, which involves formation and subsequent reduction of the corresponding oxazolidinone with a Lewis acid under mild conditions, with improved yields and shorter reaction times.

Auyuittuqamides A-D, Cyclic Decapeptides from Sesquicillium microsporum RKAG 186 Isolated from Frobisher Bay Sediment

Four new cyclic decapeptides, auyuittuqamides A-D (1-4), were obtained from Sesquicillium microsporum RKAG 186 obtained from marine sediment collected from the intertidal zone of Frobisher Bay, Nunavut, Canada. The structures of the compounds were elucida

Synthesis, stereochemical assignment, and bioactivity of the Penicillium metabolites penicillenols B1 and B2

The Penicillium metabolites penicillenols B1 and B2 were synthesised for the first time by elimination of a mesylated penicillenol A precursor as obtained from an l-threonine derived tetramic acid. The (Z,S)- and (E,S)-configured diastereomers were identical to the natural compounds as to NMR spectra and optical rotations. Both isomers showed antiproliferative effects against cancer and endothelial cell lines and penicillenol B1 was also notably antibiotic against Staphylococcus aureus.

Solid-Phase Total Synthesis of the Proposed Structure of Coibamide A and Its Derivative: Highly Methylated Cyclic Depsipeptides

The solid-phase total synthesis of the proposed structure of cyclic depsipeptide coibamide A and its derivative O-desmethyl coibamide A is reported. In this study, we demonstrate the solid-phase synthetic strategy and final solution-phase O-methylation fo